Literature DB >> 20368335

Pro-apoptotic role of Cdc25A: activation of cyclin B1/Cdc2 by the Cdc25A C-terminal domain.

Sung-Tau Chou1, Yi-Chen Yen, Chin-Mei Lee, Mei-Shya Chen.   

Abstract

Cdc25A is a dual specificity protein phosphatase that activates cyclin/cyclin-dependent protein kinase (Cdk) complexes by removing inhibitory phosphates from conserved threonine and tyrosine in Cdks. To address how Cdc25A promotes apoptosis, Jurkat cells were treated with staurosporine, an apoptosis inducer. Upon staurosporine treatment, a Cdc25A C-terminal 37-kDa fragment, designated C37, was generated by caspase cleavage at Asp-223. Thr-507 in C37 became dephosphorylated, which prevented 14-3-3 binding, as shown previously. C37 exhibited higher phosphatase activity than full-length Cdc25A. C37 with alanine substitution for Thr-507 (C37/T507A) that imitated the cleavage product during staurosporine treatment interacted with Cdc2, Cdk2, cyclin A, and cyclin B1 and markedly activated cyclin B1/Cdc2. The dephosphorylation of Thr-507 might expose the Cdc2/Cdk2-docking site in C37. C37/T507A also induced apoptosis in Jurkat and K562 cells, resulting from activating cyclin B1/Cdc2 but not Cdk2. Thus, this study reveals that Cdc25A is a pro-apoptotic protein that amplifies staurosporine-induced apoptosis through the activation of cyclin B1/Cdc2 by its C-terminal domain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20368335      PMCID: PMC2878547          DOI: 10.1074/jbc.M109.078386

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Experimental validation of the docking orientation of Cdc25 with its Cdk2-CycA protein substrate.

Authors:  Jungsan Sohn; Jerry M Parks; Gregory Buhrman; Paul Brown; Kolbrun Kristjánsdóttir; Alexias Safi; Herbert Edelsbrunner; Weitao Yang; Johannes Rudolph
Journal:  Biochemistry       Date:  2005-12-20       Impact factor: 3.162

2.  Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.

Authors:  Claus Storgaard Sørensen; Randi G Syljuåsen; Jacob Falck; Tine Schroeder; Lars Rönnstrand; Kum Kum Khanna; Bin-Bing Zhou; Jiri Bartek; Jiri Lukas
Journal:  Cancer Cell       Date:  2003-03       Impact factor: 31.743

3.  Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy.

Authors:  Karson S Putt; Grace W Chen; Jennifer M Pearson; Joseph S Sandhorst; Martin S Hoagland; Jung-Taek Kwon; Soon-Kyung Hwang; Hua Jin; Mona I Churchwell; Myung-Haing Cho; Daniel R Doerge; William G Helferich; Paul J Hergenrother
Journal:  Nat Chem Biol       Date:  2006-08-27       Impact factor: 15.040

4.  Phosphorylation of BAD at Ser-128 during mitosis and paclitaxel-induced apoptosis.

Authors:  Maria Berndtsson; Yoshiyuki Konishi; Azad Bonni; Maria Hägg; Maria Shoshan; Stig Linder; Aleksandra Mandic Havelka
Journal:  FEBS Lett       Date:  2005-06-06       Impact factor: 4.124

5.  Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases.

Authors:  Yoshinori Kanemori; Katsuhiro Uto; Noriyuki Sagata
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-21       Impact factor: 11.205

6.  An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage.

Authors:  J R Jackson; A Gilmartin; C Imburgia; J D Winkler; L A Marshall; A Roshak
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

7.  GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers.

Authors:  Tiebang Kang; Yongkun Wei; Yuchi Honaker; Hiroshi Yamaguchi; Ettore Appella; Mien-Chie Hung; Helen Piwnica-Worms
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

8.  Phosphorylation at serine 75 is required for UV-mediated degradation of human Cdc25A phosphatase at the S-phase checkpoint.

Authors:  Ingo Hassepass; Renate Voit; Ingrid Hoffmann
Journal:  J Biol Chem       Date:  2003-05-20       Impact factor: 5.157

9.  A caspase-dependent cleavage of CDC25A generates an active fragment activating cyclin-dependent kinase 2 during apoptosis.

Authors:  A Mazars; A Fernandez-Vidal; O Mondesert; C Lorenzo; G Prévost; B Ducommun; B Payrastre; C Racaud-Sultan; S Manenti
Journal:  Cell Death Differ       Date:  2008-10-17       Impact factor: 15.828

10.  Hemizygous disruption of Cdc25A inhibits cellular transformation and mammary tumorigenesis in mice.

Authors:  Dipankar Ray; Yasuhisa Terao; Dipali Nimbalkar; Hiroyuki Hirai; Evan C Osmundson; Xianghong Zou; Roberta Franks; Konstantin Christov; Hiroaki Kiyokawa
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

View more
  7 in total

Review 1.  The role of Cdc25A in the regulation of cell proliferation and apoptosis.

Authors:  Tao Shen; Shile Huang
Journal:  Anticancer Agents Med Chem       Date:  2012-07       Impact factor: 2.505

2.  CRISPR-Cas knockout of miR21 reduces glioma growth.

Authors:  Lisa Nieland; Thomas S van Solinge; Pike See Cheah; Liza M Morsett; Joseph El Khoury; Joseph I Rissman; Benjamin P Kleinstiver; Marike L D Broekman; Xandra O Breakefield; Erik R Abels
Journal:  Mol Ther Oncolytics       Date:  2022-04-06       Impact factor: 6.311

3.  Molecular network profiling of U373MG human glioblastoma cells following induction of apoptosis by novel marine-derived anti-cancer 1,2,3,4-tetrahydroisoquinoline alkaloids.

Authors:  Hiroko Tabunoki; Naoki Saito; Khanit Suwanborirux; Kornvika Charupant; Jun-Ichi Satoh
Journal:  Cancer Cell Int       Date:  2012-04-11       Impact factor: 5.722

4.  MYCT1-TV, a novel MYCT1 transcript, is regulated by c-Myc and may participate in laryngeal carcinogenesis.

Authors:  Shuang Fu; Yan Guo; Hong Chen; Zhen-Ming Xu; Guang-Bin Qiu; Ming Zhong; Kai-Lai Sun; Wei-Neng Fu
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

Review 5.  Cell-Cycle Cross Talk with Caspases and Their Substrates.

Authors:  Patrick Connolly; Irmina Garcia-Carpio; Andreas Villunger
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-06-01       Impact factor: 9.708

6.  ScreenCap3: Improving prediction of caspase-3 cleavage sites using experimentally verified noncleavage sites.

Authors:  Szu-Chin Fu; Kenichiro Imai; Tatsuya Sawasaki; Kentaro Tomii
Journal:  Proteomics       Date:  2014-08-04       Impact factor: 3.984

7.  Sirt1/Nrf2 pathway is involved in oocyte aging by regulating Cyclin B1.

Authors:  Rujun Ma; Wei Liang; Qin Sun; Xuhua Qiu; Ying Lin; Xie Ge; Kadiliya Jueraitetibaike; Min Xie; Ji Zhou; Xuan Huang; Qiang Wang; Li Chen
Journal:  Aging (Albany NY)       Date:  2018-10-27       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.